Inari Medical, Inc. reaffirmed revenue guidance for the full year 2022. For the year, company reaffirming revenue guidance range of $360 million to $370 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.23 USD | -1.85% | -4.86% | -42.70% |
Apr. 02 | Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales | CI |
Apr. 01 | Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.70% | 2.2B | |
+72.53% | 12.33B | |
-18.78% | 7.86B | |
+16.82% | 7.11B | |
+2.94% | 5.77B | |
+7.87% | 5.1B | |
+19.97% | 4.29B | |
-20.59% | 3.92B | |
-0.12% | 1.92B | |
+0.09% | 1.76B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2022